Mikhail Fedyanin, MD, PhD, Russian Academy of Medical Science, discusses future approaches for the treatment of patients with colorectal cancer (CRC).
Mikhail Fedyanin, MD, PhD
Advertisement
Articles by Mikhail Fedyanin, MD, PhD
Mikhail Fedyanin, MD, PhD, Russian Academy of Medical Science, discusses mutation discordance in the primary tumor and metastases in patients with colorectal cancer (CRC), as well as the benefits of liquid biopsy.
Mikhail Fedyanin, MD, PhD, Russian Academy of Medical Science, discusses mutation discordance in the primary tumor and metastases in patients with colorectal cancer (CRC).
Advertisement
Latest Updated Articles
Dr. Mikhail Fedyanin on Mutation Discordance in CRCPublished: October 19th 2016 | Updated:
Dr. Mikhail Fedyanin on Mutation Discordance and Liquid Biopsy in CRCPublished: November 5th 2016 | Updated:
Dr. Fedyanin on Future Treatment Landscape of CRCPublished: December 20th 2016 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
The OncFive: Top Oncology Articles for the Week of 1/25
3
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
4
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
5